Mode
Text Size
Log in / Sign up
N/A N=63 Randomized Double-blind Treatment

Effect of Mental Imagery Training on Brain Plasticity and Motor Function in Individuals With Parkinson's Disease

Parkinson Disease

Enrolled (actual)
63
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcome: Primary: Change in Right Insula-dorsomedial Frontal Cortex Functional Connectivity Strength. — 93.2; 97.8 percent change from baseline — p=0.981

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
PD neurofeedback (Other); PD control (Other)
Age
Adult, Older Adult · 40+ yrs
Sex
All
Sponsor
Yale University
Primary completion
Sep 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Right Insula-dorsomedial Frontal Cortex Functional Connectivity Strength.
93.2; 97.8 0.981
PRIMARY
Change in Resting-state Functional Connectivity Between the Right Insula and Dorsomedial Frontal Cortex.
-2.9; 74.2 0.481
PRIMARY
Change in Motor Impairment
32.3; 34.5; 31.3; 35.1 >0.05
PRIMARY
Change in Motor Function
23.7; 24.4; 22.3; 24.1 0.026 sig

Summary

Effect of Mental Imagery Training on Brain Plasticity and Motor Function in Individuals with Parkinson's Disease: A functional MRI investigation.

Eligibility Criteria

Inclusion Criteria

  • Subjects with a diagnosis of idiopathic PD defined according to the UK Brain Bank diagnostic criteria and on a stable dopaminergic medication regimen will be included.

Exclusion Criteria

  • Age 7 drinks per week for women, > 14 drinks per week for men) or substance use
  • History of a neurological disorder such as a brain tumor, stroke, central nervous system infection, multiple sclerosis, movement disorder (other than PD), or seizures
  • History of schizophrenia, bipolar disorder, attention deficit disorder, or obsessive compulsive disorder
  • History of head injury with loss of consciousness
  • Metallic surgical implants or traumatically implanted metallic foreign bodies
  • Inability to lie flat for about an hour
  • Discomfort being in small, enclosed spaces
  • Dementia (Montreal Cognitive Assessment score 19)
  • Hoehn & Yahr stage > 3 (i.e., able to stand and walk, but not fully independent)
  • Focal neurological findings on exam that suggest cerebral pathology other than that associated with parkinsonism
  • Motor symptoms that could potentially introduce too much motion artifact in the imaging data (e.g., MDS-UPDRS resting tremor score > 1 in limbs, head/chin tremor, or dyskinesia by history or exam).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03623386). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search